13 August 2013
Russian scientists are developing three types of next gen vaccines that might evolve into the revolutionary drugs for cancer, HIV and tuberculosis, Informing.ru reported , citing Vladimir Uiba, the director of Russia’s Federal Agency for Medicine and Biology.
The vaccines are currently undergoing preclinical trials, Mr. Uiba said.
According to the Agency director, he expects clinical trial testing to start in two years’ time. He underscored that “high efficacy” has been found in all the three drug candidates.
In February 2010, the Federal Agency for Medicine and Biology entered a cooperation relationship with Rusnano, Russia’s largest nanotech company. Rusnano CEO Anatoly Chubais then said that the agreement between the two partners would enable “a true breakthrough in innovation medicine.”
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Putin has stated that Russia will support Africa in the struggle against epidemics
19 April 2024
The Russian government has expanded the list of vital and essential drugs
19 April 2024
Achieving FAIR bacterial identification
18 April 2024
Unique testing regimen could prevent nuclease contamination
18 April 2024